IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Genomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting
Zhang, Wei1,2; Cheng, Shi-Yuan1,3; Hou, Li-Fang1,4; Yan, Li1,5; Tong, Yun-Guang1,6
关键词Genomics cancer personalized medicine
刊名CHINESE JOURNAL OF CANCER
2014-08-01
DOI10.5732/cjc.014.10110
33期:8页:371-375
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]PATTERNS ; CELL
英文摘要

The 6th Annual Meeting of the United States Chinese Anti-Cancer Association (USCACA) was held in conjunction with the 50th Annual Meeting of American Society of Clinical Oncology (ASCO) on May 30, 2014 in Chicago, Illinois, the United States of America. With a focus on personalized medicine, the conference featured novel approaches to investigate genomic aberrations in cancer cells and innovative clinical trial designs to expedite cancer drug development in biomarker-defined patient populations. A panel discussion further provided in-depth advice on advancing development of personalized cancer medicines in China. The conference also summarized USCACA key initiatives and accomplishments, including two awards designated to recognize young investigators from China for their achievements and to support their training in the United States. As an effort to promote international collaboration, USCACA will team up with Chinese Society of Clinical Oncology (CSCO) to host a joint session on "Breakthrough Cancer Medicines" at the upcoming CSCO Annual Meeting on September 20th, 2014 in Xiamen, China.

语种英语
WOS记录号WOS:000340075000003
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58269
专题北京大学临床肿瘤学院
作者单位1.US Chinese Anticanc Assoc USCACA, Execut Comm, Martinez, CA 94553 USA
2.Peking Univ, Sch Oncol, Beijing 100871, Peoples R China
3.Univ Illinois, Dept Pediat, Chicago, IL 60612 USA
4.Northwestern Univ Feinberg, Sch Med, Dept Neurol, Chicago, IL 60611 USA
5.Northwestern Univ Feinberg, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
6.Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Dept Med, Los Angeles, CA 90048 USA
推荐引用方式
GB/T 7714
Zhang, Wei,Cheng, Shi-Yuan,Hou, Li-Fang,et al. Genomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting[J]. CHINESE JOURNAL OF CANCER,2014,33(8):371-375.
APA Zhang, Wei,Cheng, Shi-Yuan,Hou, Li-Fang,Yan, Li,&Tong, Yun-Guang.(2014).Genomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting.CHINESE JOURNAL OF CANCER,33(8),371-375.
MLA Zhang, Wei,et al."Genomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting".CHINESE JOURNAL OF CANCER 33.8(2014):371-375.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Wei]的文章
[Cheng, Shi-Yuan]的文章
[Hou, Li-Fang]的文章
百度学术
百度学术中相似的文章
[Zhang, Wei]的文章
[Cheng, Shi-Yuan]的文章
[Hou, Li-Fang]的文章
必应学术
必应学术中相似的文章
[Zhang, Wei]的文章
[Cheng, Shi-Yuan]的文章
[Hou, Li-Fang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。